share_log

Benitec Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.9%),Citadel Advisors Holdings LP(6.9%),Citadel GP LLC(6.9%),Kenneth Griffin(6.9%),Citadel Securities LLC(0.0%),Citadel Securities Group LP(0.

Benitec Biopharma | SC 13G:超过5%持股股东披露文件-Citadel Advisors LLC(6.9%),Citadel Advisors Holdings LP(6.9%),Citadel GP LLC(6.9%),Kenneth Griffin(6.9%),Citadel Securities LLC(0.0%),Citadel Securities Group L

美股SEC公告 ·  2023/08/21 16:07
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息